Search clinical trials for: Hydroxychloroquine and Azithromycin

Total 269808 results

Institute for Research and Development of Medicinal...

Unknown

Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients (PHYTCOVID-19)

Covid19

Guinea
Apsen Farmaceutica S.A.
Federal University of São Paulo

Withdrawn

Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)

Coronavirus Infections | SARS-CoV 2 | Pulmonary Disease | SARS (Severe Acute Respiratory Syndrome)

Brazil
Institute for Research and Development of Medicinal...

Unknown

Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients (CANCOVID-19)

Covid19

Guinea
Alkarkh Health Directorate-Baghdad

Completed

Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients

IMMUNOTHERAPY

Iraq
National Institute of Allergy and Infectious Diseases...
Teva Pharmaceutical Industries, Ltd.

Terminated

Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19

COVID-19 | SARS-CoV 2

United States
University Hospital, Montpellier

Terminated

Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial) (COVIDOC)

Coronavirus Infection | Pneumonia, Viral

France
Assistance Publique - Hôpitaux de Paris

Completed

Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus (PREP-COVID)

SARS-CoV-2 Infection

France
Hospital do Coracao
Hospital Israelita Albert Einstein; Hospital Sirio-Libanes; Brazilian Research... and other collaborators

Completed

Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19) (Coalition-I)

Coronavirus Infections

Brazil
Burnasyan Federal Medical Biophysical Center

Completed

A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19

Pneumonia, Viral | Respiratory Failure

Russian Federation
Rutgers, The State University of New Jersey

Terminated

Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19

COVID-19 | SARS-CoV-2

United States
Assistance Publique - Hôpitaux de Paris

Withdrawn

Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients (MG-COVID)

Covid-19
Coordinación de Investigación en Salud, Mexico
Ultra Laboratorios SA. de CV.

Recruiting

Hidroxicloroquina With Azitromicina Versus Hidroxicloroquina and Placebo Int Patients With Mild COVID-19 (Omehecatl)

Covid19

Mexico
Latin American Cooperative Oncology Group
Oncoclínicas

Withdrawn

HOPE: A Trial of Hydroxichloroquine Plus Azithromycin in High Risk COVID-19 (HOPE_BRAZIL)

Sars-CoV2

Brazil
Iterum Therapeutics, International Limited
Waterbury Hospital

Withdrawn

Azithromycin Plus Hydroxychloroquine for COVID-19 Infection

Respiratory Tract Infection Viral

United States
Hospital Israelita Albert Einstein
Hospital do Coracao; Hospital Sirio-Libanes; Brazilian Research In Intensive... and other collaborators

Completed

Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)

Coronavirus Infections | Pneumonia, Viral

Brazil
Azidus Brasil

Suspended

Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19

Covid-19

Brazil
Rutgers, The State University of New Jersey

Withdrawn

Asymptomatic COVID-19 Trial (ACT)

SARS-CoV-2 Infection

United States
Azidus Brasil

Suspended

Efficacy and Safety of Hydroxychloroquine and Azithromycin for Patients With Moderate to Severe COVID-19

COVID-19

Brazil
Hospital St. Joseph, Marseille, France

Withdrawn

Hydroxychloroquine Azithromycin COVID-19 Pregnancy Trial (HASCOPT)

COVID19
University of California, San Francisco
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger

Chlamydia Trachomatis | Trachoma

United States, Niger
Upazila Health & Family Planning Officer's (UHFPO)...

Completed

A Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh

COVID19 | Hydroxychloroquine | Ivermectin

Bangladesh
Ministry of Health, Turkey
Istanbul University; Ankara Training and Research Hospital; Prof. Dr. Cemil Tascıoglu... and other collaborators

Active, not recruiting

Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19

COVID-19 | Sars-CoV2

Turkey
Centre Hôpital Universitaire Farhat Hached

Unknown

Hydroxychloroquine, Azithromycin in the Treatment of Covid-19 (PACTT)

COVID-19 | SARS-CoV-2 Pneumonia

Tunisia
Afyonkarahisar Health Sciences University
NeuTec Pharma

Completed

Ivermectin for Severe COVID-19 Management

COVID-19

Turkey
University Hospital, Strasbourg, France

Withdrawn

EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRA (TEACHCOVID)

Sars-CoV-2, Community-Acquired Pneumonia,COVID-19
University Hospital, Montpellier
Rheonova

Recruiting

Chronic Airway Disease, Mucus Rheology and Exacerbations (COPD-CARhE)

Chronic Obstructive Pulmonary Disease

France
Sheba Medical Center

Unknown

Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to "no Treatment" in SARS CoV 2 Virus (COSTA)

COVID - 19

Israel
Hamad Medical Corporation

Completed

Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19

Covid19

Qatar
Prof. Dr. Umar Farooq
Ayub Medical College, Abbottabad

Unknown

Effectiveness of Hydroxychloroquine in Covid-19 Patients (Covid)

COVID19

Pakistan
Almaza Military Fever Hospital

Completed

Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment

Covid19

Egypt
King Hussein Cancer Center

Withdrawn

Hydroxychloroquine in Combination With Sirolimus and Dexamethasone for Treating COVID-19 Patients (COVID19-HOPE)

COVID-19 Patients

Jordan
Shahid Sadoughi University of Medical Sciences...

Completed

Aizthromycin or Clarithromycin in H-pylori Eradication Regimen (H-pylori)

Dyspepsia | Peptic Ulcer | H-pylori

Iran, Islamic Republic of
Johns Hopkins Bloomberg School of Public Health
Bill and Melinda Gates Foundation; International Centre for Diarrhoeal Disease...

Completed

Protein Plus: Improving Infant Growth Through Diet and Enteric Health (JiVitA-6)

Stunting | Campylobacter Infections | Malnutrition; Protein | Enteric Pathogens

Bangladesh
Maimónides Biomedical Research Institute of Córdoba

Recruiting

Prevention and Treatment With Hydroxychloroquine + Azithromycin of Acute Respiratory Syndrome Induced by COVID-19 (AMBUCOV)

Covid19 | Acute Respiratory Distress Syndrome

Spain
Institut de cancérologie Strasbourg Europe

Withdrawn

Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE) (HYACINTHE)

Hematologic Malignancy | COVID19

France
University of Roma La Sapienza

Unknown

Bacteriotherapy in the Treatment of COVID-19 (BACT-ovid)

Pneumonia | Diarrhea | COVID

Italy
Yaounde Central Hospital

Unknown

Safety and Efficacy of Doxycycline and Rivaroxaban in COVID-19 (DOXYCOV)

COVID-19

Cameroon
Cairo University

Unknown

Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial

Respiratory Tract Infections
Universidad de Antioquia
Colgate Palmolive

Completed

Study on Periodontal Treatment in Diabetic Patients

Diabetes | Periodontitis | Gingivitis

Colombia
Assistance Publique Hopitaux De Marseille

Completed

Medico-economic Impact of Screening Atopobium Vaginae and Gardnerella Vaginalis in Molecular Biology by "Point-of-care" During Pregnancy (AuTop)

Low Risk of Preterm Delivery

France
Children's Hospital of Fudan University

Recruiting

Hydroxychloroquin (HCQ) in chILD of Genetic Defect

Surfactant Dysfunction

China
Radboud University Medical Center

Unknown

Autophagy Inhibition Using Hydrochloroquine in Breast Cancer Patients

Breast Cancer

Netherlands
Roberto Poscia MD, PhD

Unknown

Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora (PROBIOZOVID)

Coronavirus Infection | Pneumonia, Viral | SARS-CoV 2 | COVID

Italy
Abderrahmane Mami Hospital
Dacima Consulting; Eshmoun Clinical Research Center

Withdrawn

Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+) (COVID+PA)

Patients With COVID19

Tunisia
Intermountain Health Care, Inc.
University of Utah; Utah Department of Health

Unknown

Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19 (HyAzOUT)

COVID-19

United States
Intermountain Health Care, Inc.
University of Utah

Completed

Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19 (HAHPS)

COVID-19

United States
University of New Mexico

Terminated

Non-comparative Trial of the Combination of HCQ and AZI in the Treatment of ICU Patients

COVID-19

United States
LCMC Health

Terminated

Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease (RCT)

COVID-19

United States
Assistance Publique - Hôpitaux de Paris

Suspended

Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO (CORIMUNO-VIRO)

SARS-CoV-2 Infection | COVID19

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients (ONCOVID)

Cancer & COVID 19

France

Search clinical trials for: Hydroxychloroquine and Azithromycin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations